With trials just starting, Adar Poonawalla gets a front-row seat to the global vaccine race

The Serum Institute, which is exclusively controlled by a small and fabulously rich Indian family and started out years ago as a horse farm, is doing what a few other companies in the race for a vaccine are doing: mass-producing hundreds of millions of doses of a vaccine candidate that is still in trials and might not even work.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news